Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Celldex Therapeutics Company Profile (NASDAQ:CLDX)

Consensus Ratings for Celldex Therapeutics (NASDAQ:CLDX) (?)
Ratings Breakdown: 4 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $35.80 (28.45% upside)

Analysts' Ratings History for Celldex Therapeutics (NASDAQ:CLDX)
Show:
DateFirmActionRatingPrice TargetActions
5/5/2015Cantor FitzgeraldReiterated RatingBuy$38.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/18/2015Jefferies GroupReiterated RatingBuy$24.00 -> $36.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/11/2015Cantor FitzgeraldBoost Price TargetBuy$33.00 -> $38.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/23/2015Cowen and CompanySet Price TargetBuy$26.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/19/2014Cantor FitzgeraldSet Price TargetBuy$33.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/17/2014OppenheimerReiterated Rating$36.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/17/2014Roth CapitalBoost Price TargetBuy$40.00 -> $43.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/26/2014Cowen and CompanyInitiated CoverageOutperform$22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/28/2014Ned Davis ResearchUpgradeSell -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/4/2014Jefferies GroupBoost Price TargetBuy$29.00 -> $31.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/4/2014Cantor FitzgeraldReiterated RatingBuy$39.00 -> $33.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/4/2014OppenheimerLower Price TargetOutperform$40.00 -> $36.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/7/2013Brean CapitalReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/22/2013OppenheimerReiterated RatingBuy$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/22/2013Cantor FitzgeraldReiterated RatingBuy$39.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/22/2013Roth CapitalBoost Price TargetBuy$34.00 -> $40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/7/2013Ned Davis ResearchInitiated CoverageNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/2/2013Cantor FitzgeraldReiterated RatingBuy$39.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/2/2013OppenheimerBoost Price Target$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/24/2013GuggenheimBoost Price TargetBuy$26.00 -> $34.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/24/2013Cantor FitzgeraldBoost Price TargetBuy$39.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/23/2013Leerink SwannBoost Price TargetOutperform$28.00 -> $45.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/17/2013WedbushReiterated RatingBuy$35.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/17/2013Jefferies GroupBoost Price TargetBuy$25.00 -> $29.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/4/2013WedbushReiterated RatingOutperform$20.00 -> $35.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/7/2013OppenheimerBoost Price Target$16.00 -> $25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/7/2013Leerink SwannBoost Price Target$18.00 -> $28.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/7/2013Jefferies GroupBoost Price Target$19.00 -> $25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/24/2013Roth CapitalBoost Price TargetBuy$16.00 -> $34.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/8/2013Cantor FitzgeraldBoost Price TargetBuy$16.00 -> $24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/3/2013GuggenheimInitiated CoverageBuy$24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/21/2013OppenheimerReiterated RatingOutperform$14.00 -> $16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/19/2013Jefferies GroupReiterated RatingBuy$15.00 -> $19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/12/2013Brean CapitalBoost Price Target$14.00 -> $19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/27/2013 forward)